MRC1 and systemic sclerosis: The MHC-II+cells were decreased in bleomycin model of SSc compared with the sham treated mice(p = 0.0474, Fig. 6C), but the CD206+cells was similar between bleomycin model of SSc and sham treated mice (p = 0.1208, Fig. 6D).